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IFA

:   indirect immunoinfluscent assay
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iTRAQ
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:   Japanese encephalitis virus

mTOR

:   mechanistic target of rapamycin(serine/threonine)

NF45

:   nuclear factor 45
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:   peroxiredoxin 4
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1. Introduction {#elps5490-sec-0010}
===============

*Avibirnavirus* infectious bursal disease virus (IBDV), belonging to the Birnaviridae family, is a pathogenic agent of a highly contagious disease that damages immature B lymphocytes in the bursa of Fabricius in poultry and causes severe immunodeficiency and mortality [1](#elps5490-bib-0001){ref-type="ref"}. IBDV has a bisegmented double‐stranded RNA genome (segments A and B) [2](#elps5490-bib-0002){ref-type="ref"}. The large ORF of the segment A encodes a polyprotein that can undergo cotranslational self‐proteolytic processing and release three polypeptides, the precursor capsid protein (pVP2), the protease VP4 and the multifunctional polypeptide VP3. The small ORF in segment A encodes a nonstructural protein VP5 with a molecular weight of 17 kDa. Segment B contains a single ORF encoding the RdRp VP1 polypeptide. In 2007, a cDNA microarray was used to analyze the differentially abundant transcripts of IBDV‐infected chicken embryo fibroblasts (CEFs), which provides an overview of the mRNA profiles of cells during virus infection [3](#elps5490-bib-0003){ref-type="ref"}. However, mRNA is not always the same with the protein level. Consequently, potential cellular factors involved in viral infection are more likely obtained from the proteomic profile of the host cellular response.

Now, large‐scale screening is well recognized to be very effective for identifying host proteins of interest, many of which are unexpected and may lead to new discoveries regarding the host--virus interactions after additional functional validation. In the past decade, researchers have been paying increasingly close attention to the host response to virus infection at the translational level. 2DE coupled with MALDI‐TOF MS has been widely applied to detecting the dynamics of host--pathogen interactions at various stages of virus infection [4](#elps5490-bib-0004){ref-type="ref"}, [5](#elps5490-bib-0005){ref-type="ref"}, [6](#elps5490-bib-0006){ref-type="ref"}, [7](#elps5490-bib-0007){ref-type="ref"}, [8](#elps5490-bib-0008){ref-type="ref"}, [9](#elps5490-bib-0009){ref-type="ref"}, [10](#elps5490-bib-0010){ref-type="ref"}, [11](#elps5490-bib-0011){ref-type="ref"}, [12](#elps5490-bib-0012){ref-type="ref"}. However, proteins with low abundance and those that are very large or very small have been proven to be difficult to resolve using 2DE gels [13](#elps5490-bib-0013){ref-type="ref"}.

Using isobaric tags for relative and absolute quantification (iTRAQ) combined with LC and ESI**‐**MS/MS analysis is emerging as a powerful methodology in the search for disease‐specific targets [14](#elps5490-bib-0014){ref-type="ref"}. In the past few years, iTRAQ has been used to explore and discover previously unidentified factors in the cell proteomic response to infection with porcine circovirus type 2 [15](#elps5490-bib-0015){ref-type="ref"}, porcine reproductive and respiratory syndrome virus [16](#elps5490-bib-0016){ref-type="ref"}, human immunodeficiency virus 1 [17](#elps5490-bib-0017){ref-type="ref"}, human papilloma virus [18](#elps5490-bib-0018){ref-type="ref"}, simian immunodeficiency virus [19](#elps5490-bib-0019){ref-type="ref"} and influenza virus [20](#elps5490-bib-0020){ref-type="ref"}. However, iTRAQ was rarely used to determine the subcellular proteomic response to IBDV infection. In this study, we utilized an iTRAQ‐based quantitative subcellular proteomics approach followed by bioinformatic analysis and Western blot coupled with quantitative real‐time RT‐PCR and colocalization assays to observe the differentially abundant proteins profiles of IBDV‐infected cells at 24 h after inoculation. We find that viral infection regulates the abundance and/or subcellular localization of more than 1000 host proteins in either the nuclear or the cytoplasmic fraction at the early phase of infection. These data provide clues to further understanding the replication and pathogenesis of IBDV and virus--host interactions.

2. Materials and methods {#elps5490-sec-0020}
========================

2.1. Cell culture, virus infection, and sample preparation {#elps5490-sec-0030}
----------------------------------------------------------

IBDV NB strain with CPE characteristics, including the infected cells became round, increasing light refrangibility, netting, and nucleus broken, was propagated in CEF as previously described [21](#elps5490-bib-0021){ref-type="ref"}, [22](#elps5490-bib-0022){ref-type="ref"}. DF‐1 cells (ATCC CRL‐12203) were continuous cell line of CEF and routinely cultured at 39°C with 5% CO~2~ in DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (GibcoBRL Life Technologies, Grand Island, NY). DF‐1 cell monolayers were inoculated with the NB strain (10^7.2^ TCID~50~/0.1 mL) at a multiplicity of infection (MOI) of 1. Mock‐infected DF‐1 cells were used as the negative control. The IBDV‐ and mock‐infected cells were harvested at 24 h postinfection (hpi) through scraping followed by centrifugation at 5000 × *g* for 10 min. Each sample of cells was washed thrice with ice‐cold PBS followed by subcellular fractionation.

2.2. Flow cytometry analysis {#elps5490-sec-0040}
----------------------------

IBDV‐ and mock‐infected DF‐1 cells were harvested at 24 hpi for the flow cytometric determination of IBDV infection [23](#elps5490-bib-0023){ref-type="ref"}. Cells were washed twice with 1× PBS followed by fixation in 4% paraformaldehyde at room temperature for 30 min and subsequently permeabilized with 0.1% Triton X‐100 in PBS for 10 min at room temperature. After washing twice with PBS, cells were incubated with the FITC‐labeled anti‐VP4 mAb at 4°C for 1 h in the dark. Cells were washed twice with 1× PBS, resuspended in 1 mL PBS, and analyzed by the flow cytometry (Beckman Coulter, Miami) using Flowjo7.6^TM^ software. The percentage of IBDV--positive cells was calculated from the FITC fluorescence histogram using a region that was defined based on analysis of the noninfected control.

2.3. Subcellular fractionation {#elps5490-sec-0050}
------------------------------

According to the manufacturer\'s instructions, cytosolic and nuclear protein fractions were sequentially extracted by the ProteoExtract® Subcellular Proteome Extraction Kit (Merck, Darmstadt, Germany). Briefly, cells were harvested by centrifugation at 600 × *g* for 10 min at 4°C and washed twice with cold wash buffer. Thereafter, the cells were resuspended in 1 mL of cytosol extraction buffer containing protease inhibitor cocktail (included in the fractionation kit), incubated for 10 min at 4°C with gentle agitation and centrifuged at 4°C at 800 × *g* for 10 min. The resultant supernatant was harvested and considered as the cytosolic fraction. The membranes and membrane organelles were dissolved with extraction buffer II. Subsequently, the pellets were resuspended in 500 μL nuclear extraction buffer containing a protease inhibitor mixture and Benzonase® Nuclease, incubated at 4°C for 10 min and centrifuged at 7000 × *g* for 10 min. The supernatant containing predominantly nuclear proteins was collected. Finally, protein concentrations were measured using a BCA Protein Assay Kit (Novagen, Darmstadt, Germany).

2.4. Protein digestion, peptide quantitative, and iTRAQ labeling {#elps5490-sec-0060}
----------------------------------------------------------------

In the light of the previously FASP (filter aided sample preparation) procedure, proteins were digested [24](#elps5490-bib-0024){ref-type="ref"}. First, 300 μg of protein for each sample was merged into 30 μL STD buffer (100 mM DTT, 4% SDS, 150 mM Tris‐HCl pH 8.0). Next, UA buffer (8 M Urea, 150 mM Tris‐HCl pH 8.0) removed the DTT and detergent components by ultrafiltration (Microcon units, 30 kDa). Afterwards, the samples were incubated with 100 μL 0.05 M iodoacetamide in UA buffer for 20 min in the dark. At last, 40 μL trypsin buffer (2 μg trypsin in 40 μL dissolution buffer) was added to the protein suspensions digested overnight at 37°C. The peptides were measured by UV density at 280 nm.

Each sample about 32 μg was labeled using iTRAQ reagent 8‐plex Multiplex Kit in accordance with the manufacturer\'s instructions (Applied Biosystems). The cytoplasmic fractions (F1) of IBDV‐infected samples including three biological repeats were labeled as (Sample1)‐113, (Sample2)‐114 and (Sample3)‐115, respectively, while mock‐infected samples were labeled as (Sample4)‐116, (Sample5)‐117 and (Sample6)‐118. The nuclear fraction (F2) samples were labeled similarly.

2.5. Peptide fractionation and LC‐MS/MS analysis {#elps5490-sec-0070}
------------------------------------------------

Peptides labeled with iTRAQ were fractionated by strong cation exchange (SCX) chromatography using the AKTA Purifier system (GE Healthcare). After reconstituted and acidified with 2 mL buffer A (10 mM KH~2~PO~4~ in 25% of ACN, pH 2.7), the dried peptide mixture was loaded onto a PolySULFOETHYL 4.6 × 100 mm column (5 μm, 200 Å, PolyLC, MD, USA). Then, the peptides were eluted at flow velocity of 1 mL/min with a gradient of 0--10% buffer B (500 mM KCl, 10 mM KH~2~PO~4~ in 25% of ACN, pH 2.7) for 2 min, 10--20% buffer B for 25 min, 20--45% buffer B for 5 min, and 50--100% buffer B for 5 min. The fractions were collected every 1 min and the elution process was monitored by absorbance at 214 nm. The collected fractions were desalted on C18 Cartridges (Empore™ SPE Cartridges C18 \[standard density\], bed id 7 mm, volume 3 mL, Sigma) and then combined into six pools. Each fraction was concentrated by vacuum centrifugation following reconstituted in 40 μL of 0.1% (v/v) TFA. Afterwards, the samples were performed using Q Exactive mass spectrometer that was coupled with the Easy nLC apparatus (Thermo Fisher Scientific). The samples were added into C18‐RP column (10 cm long, 75 μm inner diameter, 3 μm resin) in buffer A (0.1% formic acid in water), and then separated with buffer B (80% ACN in 0.1% formic acid) by IntelliFlow technology. The MS data were collected in accordance with following methods: after each full scan collected ten fragment patterns (MS2 scan).

2.6. Database search and quantification analysis {#elps5490-sec-0080}
------------------------------------------------

MS/MS data were searched and quantified using Maxquant (version: 1.3.0.5, Max Planck Institute of Biochemistry, Martinsried, Germany). The search identification was based on the Uniprot *Gallus gallus* (29 345 sequences, downloaded on March 25, 2013) and Uniprot IBDV (2692 sequences, downloaded on June 20, 2013) databases. The parameters of protein identification were as follows: peptide mass tolerance = 20 ppm, MS/MS tolerance = 0.1 Da, enzyme = trypsin, missed cleavage = 2; fixed modification: carbamidomethyl (C), iTRAQ8plex (K), iTRAQ8plex (N‐term), variable modification: oxidation (M), FDR ≤ 0.01. The protein identification that was inferred from the unique peptide identification in three independent biological replicates was considered. In addition, a *p*‐value less than 0.05 was considered to be statistically significant. The fold changes ≥1.2 or ≤0.83 of proteins were designated significant.

2.7. Quantitative real‐time RT‐PCR {#elps5490-sec-0090}
----------------------------------

We have designed specific primers (Supporting Information Table 1) to amplify target genes corresponding to the MS/MS‐identified proteins. Using cDNA from IBDV‐infected DF‐1 cells, gene products were analyzed using the 7500 real‐time PCR system (Applied Biosystems). The reaction contained 200 ng of cDNA template, 200 nM of each primer, and 1× SYBR premix Ex Taq (Perfect Real Time, TakaRa, Dalian, China), supplemented with water to a total volume of 20 μL. After an initial denaturation at 95°C for 30 s, the samples were amplified by 40 cycles of 95°C for 5 s and 60°C for 34 s. We obtained the melting curves, and then performed quantitative analysis of the data by the 7500 System SDS software version 1.3.1 (Applied Biosystems) with relative quantification (cycle threshold \[ΔΔCt\]) method. Simultaneously, mock‐infected samples in parallel were used as negative controls.

2.8. Western blot analysis {#elps5490-sec-0100}
--------------------------

In order to evaluate the differentially abundant proteins identified by iTRAQ‐labeled LC‐MS/MS system, IFN‐induced protein with tetratricopeptide repeats 5 (IFIT5), signal transducer and activator of transcription 1 (STAT1), nuclear factor 45 (NF45), heterogeneous nuclear ribonucleoprotein H1 (hnRNPH1), and apoptosis inhibitor 5 (API5) were selected for Western blot analysis. Equal amounts of proteins from each sample were separated on 8% SDS‐PAGE gels and transferred to NC membranes (Amersham Biosciences, Berks, UK) by using a semidry transfer cell (Bio‐Rad Trans‐blot SD). The membranes were blocked with 5% nonfat dried milk and then stained with a rabbit anti‐STAT1 mAb (Epitomics, Cambridge, UK), mouse polyclonal antibody (pAb) to IFIT5 prepared in our laboratory (unpublished data), goat anti‐NF45 pAb, goat anti‐hnRNPH1 pAb, rabbit anti‐API5 pAb, or rabbit anti‐API5 pAb (Santa Cruz Biotechnology, Santa Cruz, CA). After washing three times with 0.05% Tween‐20 in PBS (PBST), the membranes were incubated with horseradish peroxidase (HRP) conjugated goat anti‐mouse IgG, HRP‐conjugated goat anti‐rabbit IgG, or HRP‐conjugated donkey anti‐goat IgG (Kirkegarard & Perry Laboratories, Gaithersburg, MD) at 37°C for 1 h. Finally, the detection was performed using chemiluminescence luminal reagents (SuperSignalWest Pico Trial Kit, Pierce, Rockford, IL).

2.9. Confocal immunofluorescence assay {#elps5490-sec-0110}
--------------------------------------

DF‐1 cells inoculated with IBDV at MOI = 1 were cultured for 24 h. At the end of this infection period, the cells were fixed with cold acetone/methanol (1/1) for 20 min at −20°C, and then dried in air. Fixed cells were incubated with a pAb adding to the NF45, hnRNPH1, API5, nuclear protein localization protein 4 (NPL4), and DDX42 at 37°C for 90 min. After washing three times with PBST, the cells were incubated with FITC‐conjugated goat anti‐rabbit IgG (Sigma), FITC‐conjugated rabbit anti‐goat IgG, and Alexa Fluor 566 goat anti‐mouse IgG (Life Technologies) for 1 h at 37°C. Next, cell nuclei were stained blue using 4′,6‐diamidino‐2‐phenylindole (DAPI, Sigma). Finally, the cells were washed three times with PBS and visualized using a Zeiss LSM780 laser confocal microscope.

2.10. Protein networks analysis {#elps5490-sec-0120}
-------------------------------

In order to gain further insight into the most relevant interaction networks and biological functions of the differentially abundant proteins, data of all proteins were analyzed using Ingenuity Pathway Analysis (IPA, Ingenuity Systems, <http://www.ingenuity.com>). Network construction was carried out as described previously [25](#elps5490-bib-0025){ref-type="ref"}. In other words, we uploaded differentially abundant proteins (showing fold change of ≥1.2 or ≤0.83) identified into the IPA application, and then constructed the interaction network. Possible connections between those mapped genes were evaluated on the basis of knowledge curated in the IPA database. Each protein represented a node, and the interaction relationships between the nodes were linked by line. The linkages have been supported by at least one or more reference. Different shapes and the color of nodes represented differentially abundance and the functional classes of the proteins, respectively. Furthermore, IPA‐curated canonical pathways were used to explore possible metabolic and cell signaling pathways.

3. Results {#elps5490-sec-0130}
==========

3.1. Quantitative subcellular proteome of IBDV‐infected DF‐1 cells {#elps5490-sec-0140}
------------------------------------------------------------------

For analysis of the subcellular proteome, DF‐1 cells were first infected with IBDV for 12, 18, 21, and 24 h. To select the optimal time point for iTRAQ analysis, virus infection profiles were identified by IFA using a mAb to VP3 protein of IBDV as the primary antibody. IFA results revealed that IBDV‐specific immunofluorescence was observed at 12, 18, 21, and 24 hpi (with the monolayer appearing nearly 90% positive at the last time point), but not in mock‐infected DF‐1 cells (Fig. [1](#elps5490-fig-0001){ref-type="fig"}A). Additionally, we confirmed the rate of infection by flow cytometry (Fig. [1](#elps5490-fig-0001){ref-type="fig"}B), which showed that the percentage of IBDV‐positive cells was 99.4 ± 0.2% at 24 hpi. These results indicated that 24 hpi would be the best sample collection time point for iTRAQ analysis. Therefore, cytoplasmic and nuclear fractions were extracted from the cells at 24 hpi. The enrichment of proteins in these two fractions was confirmed by Western blot using GAPDH as a cytoplasmic protein marker and histone 3 as a nuclear protein marker (Fig. [1](#elps5490-fig-0001){ref-type="fig"}C). The result showed that the protein markers GAPDH and histone 3 appeared in cytoplasm and nucleus, respectively, indicating the procedure used for cytoplasmic and nuclear fractionation was suitable for iTRAQ analysis.

![Confirmation of DF‐1 cells infected with IBDV. (A) Detection of IBDV in DF‐1 cells with IFA. Mock‐ and IBDV‐infected DF‐1 cells were collected at 12, 18, 21, and 24 hpi and stained with mAb to IBDV VP3 protein followed by FITC‐labeled IgG (green). (B) Quantification of infected cells by flow cytometry. IBDV‐ and mock‐infected DF‐1 cells were assayed by single‐color flow cytometric analysis. This figure shows the percentage of IBDV‐infected cells at 24 hpi. Cells were stained with anti‐VP4 mAb labeled with FITC. Mock‐infected DF‐1 cells served as a negative control (blue line). The mean percentage ± SD of infected cells from a representative experiment performed in triplicate was 99.4 ± 0.2%. (C) Detection of the cytoplasmic and nuclear fractions from IBDV‐ and mock‐infected cells by Western blotting. GAPDH and histone H3 were used as markers of cytoplasmic and nuclear proteins, respectively. IBDV viral proteins VP3 and VP4 were used as markers of infection.](ELPS-36-1596-g001){#elps5490-fig-0001}

3.2. Protein profiling by iTRAQ coupled LC‐MS/MS analysis {#elps5490-sec-0150}
---------------------------------------------------------

Protein identification and quantification from cytoplasmic fraction and nuclear fraction were performed, respectively, using 6‐plex iTRAQ labeling combined with LC‐MS/MS analysis. Two fractions iTRAQ sample sets were analyzed, including three independent biological replicates of cytoplasmic and nuclear fractions (Supporting Information Fig. 1). Based on the LC‐MS/MS data, 1152 and 2117 proteins were identified from the cytoplasmic and nuclear cell fractions, respectively. Of the identified proteins, we reliably quantified 3211 proteins, of which 23 and 34 proteins were differentially abundant proteins in the cytoplasmic and nuclear fractions (fold changes ≥1.2 or ≤0.83) as a result of infection [26](#elps5490-bib-0026){ref-type="ref"}, respectively (Table [1](#elps5490-tbl-0001){ref-type="table"}, Fig. [2](#elps5490-fig-0002){ref-type="fig"}A). However, of 57 identified proteins, 19 proteins were identified by one unique peptide from three biological replicates, the MS/MS spectrum for each of these proteins are included in Supporting Information Fig. 2. In addition, these differentially abundant proteins were clustered hierarchically with Cluster 3.0 software (Fig. [2](#elps5490-fig-0002){ref-type="fig"}B). Based on this analysis, these proteins were found to belong to two groups where the amount of protein increased and decreased at 24 hpi in the cytoplasmic and nuclear fractions, respectively.

###### 

Differentially abundant proteins in IBDV‐infected DF‐1 cells by iTRAQ analysis. The 57 unique proteins identified

  UniProt data                           Protein                                                                          Gene       Sequence   Unique   p*I*    Ratio[e)](#elps5490-tbl1-note-0005){ref-type="fn"}   *t*‐Test *p*‐   Function
  -------------------------------------- -------------------------------------------------------------------------------- ---------- ---------- -------- ------- ---------------------------------------------------- --------------- -----------------------------------------------------------------------------------------------
  *Upregulated cytoplasmic proteins*                                                                                                                                                                                                  
  P18302                                 Drebrin                                                                          DBN1       2.1        1        4.16    2.22                                                 0.00006         Actin binding and profilin binding
  F1P3J2                                 Uncharacterized                                                                  IFIT5      2.4        1        5.50    2.00                                                 0.00018         Type I interferon mediated signaling pathway
  F1NJ08                                 Vimentin                                                                         VIM        31.3       13       4.85    1.64                                                 0.00001         Integrity of the cytoplasm, immune response
  E1C2F2                                 Pinpin                                                                           PNN        1.9        1        6.71    1.58                                                 0.01102         Participates in the regulation of alternative pre‐mRNA splicing
  F1NEG6                                 Uncharacterized                                                                  hnRNPH1    4.6        3        5.50    1.51                                                 0.00714         mRNA processing
  P13648                                 Lamin A                                                                          Lamin A    3.3        2        6.93    1.47                                                 0.01063         Structural molecule activity protein binding
  P16039                                 Nucleophosmin                                                                    NPM1       21.4       6        4.39    1.42                                                 0.00008         Transcription coactivator activity
  Q9YIC3                                 FK506‐binding protein 9                                                          FKBP       2.8        1        4.76    1.42                                                 0.00302         Peptidyl‐prolyl *cis--trans* isomerase activity
  F1NZA1                                 Uncharacterized                                                                  TTLL12     3          2        4.84    1.37                                                 0.00084         Cellular protein modification process
  Q5F3D2                                 Uncharacterized                                                                  hnRNPH3    9.4        2        7.13    1.33                                                 0.00204         Involved in the splicing process and participates in early heat shock‐induced splicing arrest
  Q07598                                 Nonspecific lipid‐transfer protein                                               SCP2       2          1        8.30    1.33                                                 0.00102         Fatty‐acyl‐CoA binding and receptor binding transfer protein
  E1C8Y9                                 Uncharacterized                                                                  SRF3       17.1       3        12.14   1.29                                                 0.03277         mRNA processing and regulating alternative splicing
  Q5ZML3                                 Serine/arginine‐rich splicing factor 1                                           SRSF1      30         8        6.95    1.27                                                 0.00051         mRNA processing and regulating alternative splicing
  E1BQK9                                 Uncharacterized                                                                  CUL4B      1.4        1        8.03    1.25                                                 0.02890         Ubiquitin protein ligase binding
  Q5F3E8                                 BTB/POZ domain containing adapter for CUL3‐mediated RhoA degradation protein 3   TNFAIP1    4.8        1        7.88    1.25                                                 0.01300         Negative regulation of Rho protein signal transduction
  F1NZD3                                 Uncharacterized                                                                  RBMX       11.2       4        10.49   1.23                                                 0.00049         Plays several role in the regulation of pre‐ and posttranscriptional processes
  P09102                                 Protein disulfide isomerase                                                      PDIA1      12         7        4.42    1.20                                                 0.01984         Protein disulfide oxidoreductase activity
  I3VQH4                                 Interleukin enhancer binding factor 3                                            ILF3       4.3        1        9.14    1.17                                                 0.0005          Double‐stranded RNA binding and RNA binding
  H9KZT7                                 Uncharacterized                                                                  NF45       5.9        2        5.10    1.10                                                 0.0459          Double‐stranded RNA binding and RNA binding
  *Downregulated cytoplasmic proteins*                                                                                                                                                                                                
  E1C115                                 Uncharacterized                                                                  EIF4EBP1   7.8        1        4.39    0.83                                                 0.00097         Eukaryotic initiation factor 4E binding
  Q90ZG0                                 Peptidyl‐prolyl *cis--trans* isomerase                                           PPIA       25         2        8.48    0.83                                                 0.00057         Mediates ERK1/2 activation
  A7UEA7                                 Multifunctional protein ADE2                                                     PAICS      8.5        4        8.33    0.82                                                 0.00022         Purine nucleobase biosynthetic process
  E1BYW9                                 Proteasome subunit beta type                                                     PSMB3      4.4        1        5.05    0.81                                                 0.00195         Cleave peptides in an ATP/ubiquitin‐dependent process in a nonlysosomal pathway
  F1NNS8                                 Uncharacterized                                                                  PRDX4      5.2        1        8.57    0.77                                                 0.01341         Activation of the transcription factor NF‐kappa B
  F1NY51                                 Uncharacterized                                                                  UCHL3      10         2        4.64    0.77                                                 0.01857         Catalyze the removal of ubiquitin from polypeptides
  *Upregulated nuclear proteins*                                                                                                                                                                                                      
  E1C2Y5                                 C‐C Motif chemokine 4 homolog                                                    CCL4       8.9        4        9.33    1.96                                                 0.00758         Receptor for a C‐C type chemokine
  E1C8B5                                 Uncharacterized                                                                  KIN        5.6        2        9.49    1.39                                                 0.00504         DNA replication and the cellular response to DNA damage
  Q5ZK63                                 Activated RNA polymerase II transcriptional coactivator p15                      TCP4       44.4       3        10.29   1.38                                                 0.00188         Transcription coactivator activity
  Q5ZL92                                 Eukaryotic translation initiation factor 6                                       EIF6       19.1       11       4.30    1.37                                                 0.00621         Translation initiation factor activity
  F1NH66                                 Uncharacterized                                                                  EML4       1.6        1        6.25    1.30                                                 0.00005         May modify the assembly dynamics of microtubules
  Q5ZJK3                                 Signal transducer and activator of transcription                                 STAT1      12.2       8        5.80    1.26                                                 0.00065         Mediates cellular responses to interferons
  F1NZJ2                                 Uncharacterized                                                                  HK1        18.6       1        6.72    1.26                                                 0.03647         Metabolism pathways
  F1P222                                 LDLR chaperone MESD                                                              MESDC2     30.2       7        6.80    1.22                                                 0.00101         Acts as a modulator of the Wnt pathway
  E1C214                                 Ubiquitin carboxyl terminal hydrolase 16 isoform x2                              UBP16      1.5        1        5.75    1.22                                                 0.00004         Ubiquitin‐specific protease activity
  F1NA16                                 Uncharacterized                                                                  SREK1      2.1        1        10.69   1.22                                                 0.03237         Participates in the regulation of alternative splicing
  E1BZH9                                 Uncharacterized                                                                  HADH       15.2       5        9.16    1.21                                                 0.00227         Metabolic pathways
  E1BVT3                                 Malate dehydrogenase                                                             MDH2       52.5       16       8.73    1.21                                                 0.00038         Operates in the metabolic coordination between cytosol and mitochondria
  F1NR57                                 Uncharacterized                                                                  SLC2A11    1.9        2        6.89    1.20                                                 0.00054         Facilitative glucose transporter
  O93257                                 X‐ray repair cross‐complementing protein                                         XRCC6      9.2        5        6.02    1.20                                                 0.03621         ssDNA‐dependent ATP‐dependent helicase
  E1BZJ3                                 Uncharacterized                                                                  NPL4       8.9        4        6.34    1.11                                                 0.0075          Protein binding and zinc ion binding
  Q5ZMW3                                 Apoptosis inhibitor                                                              API5       44.4       3        7.45    1.10                                                 0.0071          Inhibiting apoptosis
  *Downregulated nuclear proteins*                                                                                                                                                                                                    
  F1NRD9                                 ATP‐dependent RNA helicase                                                       DDX1       19.5       11       6.89    0.93                                                 0.0291          Enhance NF‐kappa B mediated transcriptional activation
  E1C2E3                                 Uncharacterized                                                                  VDAC3      20.5       6        9.25    0.85                                                 0.0500          Porin activity and nucleotide binding
  F1NPD3                                 60S ribosomal protein l18a                                                       RPL18A     17         3        11.40   0.83                                                 0.00034         Structural constituent of ribosome and RNA
  Q5ZMD0                                 Uncharacterized                                                                  NOP56      6.2        3        9.65    0.82                                                 0.00327         Involved in the early to middle stages of 60S ribosomal subunit biogenesis
  F1NC34                                 Uncharacterized                                                                  SLC35B2    4.9        2        9.33    0.82                                                 0.01273         May indirectly participate in activation of the NF‐kappa B and MAPK pathways
  P53449                                 Fructose‐bisphosphate aldolase C                                                 ALDOC      35.8       3        6.51    0.82                                                 0.00034         Glycolytic enzymes
  A0M8T8                                 Caveolin‐1                                                                       CAV1       24.2       4        6.23    0.82                                                 0.02114         Structural molecule activity and receptor binding activity and receptor binding
  Q5ZJZ5                                 [d]{.smallcaps}‐Beta‐hydroxybutyrate mitochondrial                               BDH1       3.2        1        9.58    0.82                                                 0.01216         Phospholipid binding and 3‐hydroxybutyrate dehydrogenase activity
  E1C6C9                                 Uncharacterized                                                                  NDUFB10    12         2        6.27    0.82                                                 0.03815         NADH dehydrogenase (ubiquinone) activity
  Q7T2Z7                                 Collagen alpha‐1 chain                                                           COL1A1     3.8        1        7.47    0.81                                                 0.00414         Cell growth and repair
  Q5ZMF9                                 Uncharacterized                                                                  DERL1      4.4        1        9.58    0.81                                                 0.01588         Participate in the endoplasmic reticulum associated degradation response
  P22451                                 60S ribosomal protein l5                                                         RPL5       22.9       7        10.22   0.80                                                 0.00758         RNA binding
  P61355                                 60S ribosomal protein l27                                                        RPL27      18.4       3        11.23   0.80                                                 0.01773         Structural constituent of ribosome
  F1N9I7                                 Probable carboxypeptidase pm20d1                                                 PM20D1     1.5        1        7.22    0.79                                                 0.04083         Metabolic process
  F1P0H9                                 Collagen alpha‐2 (I) chain                                                       COL1A2     26.8       25       9.68    0.79                                                 0.01093         Cell growth and repair
  F1NH93                                 Uncharacterized                                                                  RPS20      19.7       2        10.71   0.77                                                 0.00008         Structural constituent of ribosome and RNA binding
  Q5F491                                 Uncharacterized                                                                  DDX42      22         11       6.99    0.77                                                 0.0004          RNA binding and ATP‐dependent helicase activity
  Q2MCJ7                                 Aquaporin‐1                                                                      AQP1       7.4        1        6.91    0.76                                                 0.00052         Water channel activity and transporter activity
  F1NFE0                                 Collagen alpha‐1(VI) chain                                                       COL6A1     18.1       14       5.65    0.76                                                 0.01548         Acts as a cell‐binding protein
  F1NJT3                                 Fibronectin                                                                      FINC       16.1       34       5.34    0.74                                                 0.00113         Involved in cell adhesion and migration processes
  P15988                                 Collagen alpha‐2 (VI) chain                                                      COL6A2     16.9       16       5.61    0.74                                                 0.00006         Acts as a cell‐binding protein
  P02457                                 Collagen alpha‐1 (I) chain                                                       COL1A1     45.6       45       5.21    0.73                                                 0.00004         Cell growth and repair

a\) Protein IDs according to UniProt.

b\) Protein name of the proteins identified by iTRAQ with LC‐MS/MS.

c\) Percent sequence coverage of identified proteins.

d\) Number of unique peptides identified for each protein (in three independent biological replicates).

e\) Ratios of IBDV‐infected/mock‐infected.

f\) *p*‐Value of significant index.
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![Statistical analysis of quantitative subcellular proteomic data from IBDV‐infected DF‐1 cells. (A) Quantitative analysis using numbers of differentially abundant proteins in cytoplasmic and nuclear fractions. (B) Hierarchical cluster analysis for differentially abundant proteins in cytoplasmic and nuclear fractions. Differentially abundant proteins are shown with a pseudocolor scale (from −3 to 3) indicating high (red) and low (green) abundance. (C) Classification of proteins in different fractions using gene ontology. All identified proteins in cytoplasmic, nuclear, lysosomal, mitochondrial, and endoplasmic reticulum were annotated.](ELPS-36-1596-g002){#elps5490-fig-0002}

3.3. Bioinformatics analysis of differentially abundant proteins {#elps5490-sec-0160}
----------------------------------------------------------------

In order to understand our proteomic profiles, the identified and quantified proteins were analyzed further by different bioinformatic tools. The numbers of proteins for different subcellular location were quantified using the gene ontology (GO) annotations (Fig. [2](#elps5490-fig-0002){ref-type="fig"}C). It can be seen that cytoplasmic localization of proteins annotated was the largest proportion in the cytoplasmic fraction. Similarly, nuclear proteins were most abundant in the nuclear fraction. Additionally, some proteins showed cytoplasmic annotation using our dataset also appeared in the nuclear fraction. Thus, some proteins apparently had shifted between the nucleus and cytoplasm after IBDV infection.

Simultaneously, to better understand the implications of host responses to IBDV infection, we analyzed the differentially abundant proteins with the "biological process" GO annotation. Shown in Fig. [3](#elps5490-fig-0003){ref-type="fig"}, about half of the proteins are involved in regulation of cellular, metabolic, and biological processes. Based on the statistical analysis of cytoplasmic proteins, the cell proliferation, developmental process, multicellular organismal process, and locomotion were identified in the upregulated proteins (Fig. [3](#elps5490-fig-0003){ref-type="fig"}A, in red), indicating that these processes were more active inside the cytoplasm after IBDV infection. Interestingly, these processes were found in the downregulated nuclear fraction (Fig. [3](#elps5490-fig-0003){ref-type="fig"}B, in red), but not in the upregulated nuclear fraction. The above data showed a dynamic shift of differentially abundant proteins between the cytoplasm and nucleus.

![Biological processes analysis of differentially abundant proteins based on gene ontology. (A) Relative proportions of various proteins that were increased or decreased in abundance in the cytoplasmic fraction. (B) Relative proportions of various proteins that were increased or decreased in abundance in the nuclear fraction. Percentages of protein numbers in each category are displayed in brackets.](ELPS-36-1596-g003){#elps5490-fig-0003}

3.4. Assessment of mRNA transcript {#elps5490-sec-0170}
----------------------------------

We assessed the mRNA abundance of 25 identified proteins by quantitative real‐time RT‐PCR (Fig. [4](#elps5490-fig-0004){ref-type="fig"}). These proteins had differentially abundant in MS/MS. The *GAPDH* mRNA transcript was used as a control housekeeping gene. In general, most of the change trends of 25 mRNA were similar to their proteins in iTRAQ analysis (Table [1](#elps5490-tbl-0001){ref-type="table"}). Among these genes, the abundance of the innate immune associated genes *IFIT5* [27](#elps5490-bib-0027){ref-type="ref"} and *STAT1* were evidently increased, while the genes eukaryotic translation initiation factor 4E binding protein 1 (*EIF4EBP1*), DEAD‐box RNA helicase 1 (*DDX1*), and DEAD‐box RNA helicase 42 (*DDX42*) were decreased. Transcriptional levels of chemokinetic and inflammatory associated genes c‐c motif chemokine 4 homolog (*CCL4)* and FK506 Binding Protein (*FKBP*) were increased. Similarly, metabolic process and signaling associated genes *hnRNPH1*, interleukin enhancer‐binding factor 3 (*ILF3*), *NPL4*, and *NF45* were also increased, but the transcription of antioxidant enzyme gene peroxiredoxin 4 (*PRDX4*) was decreased in abundance. Additionally, although the mRNA level of apoptosis inhibitor associated gene *API5* was increased, that of the voltage‐dependent anion channel 3 (*VDAC3*) gene was decreased. A variety of factors can affect gene expression. In this study, changes in mRNA of most genes were consistent with its corresponding protein abundance, which indicated these proteins may be regulated at the mRNA level.

![Transcriptional profiling of differentially abundant proteins in IBDV‐infected DF‐1 cells. The mRNA changes of IBDV‐infected cells was detected by real‐time RT‐PCR. All samples were normalized to the *GAPDH* gene as a control. The fold increase or decrease was relative to mock‐infected cells as the reference. Error bars represent SDs.](ELPS-36-1596-g004){#elps5490-fig-0004}

3.5. Validation of changes in protein levels for differentially abundant proteins {#elps5490-sec-0180}
---------------------------------------------------------------------------------

To provide additional evidence to validate the differentially abundant proteins identified by the iTRAQ‐labeled LC‐MS/MS system, five proteins in both the cytoplasmic and nuclear fractions (IFIT5, hnRNPH1, NF45, API5, and STAT1) were detected by Western blot analysis (Fig. [5](#elps5490-fig-0005){ref-type="fig"}). GAPDH and histone 3 were used as the marker and loading controls of cytoplasmic and nuclear proteins, respectively. The significant increases of IFIT5 were observed in the cytoplasmic fractions of IBDV‐infected cells. The abundance of the nuclear STAT1 protein was identified as increase in the nuclear fractions by MS analysis, and the Western blot results supported this observation. The API5 protein was shown to be nonsignificantly increased in abundance in the nucleus of IBDV‐infected cells compared with mock‐infected cells, which was consistent with the MS results. However, the intracytoplasmic API5 protein was significantly increased in abundance, which was not found in the MS analysis. Significant increases of NF45 and hnRNPH1 were observed in the cytoplasmic fraction of IBDV‐infected cells. Interestingly, NF45 mostly appeared in the nucleus, but then shifted to the cytoplasm after IBDV infection. Generally, except for API5, the change trends in protein abundance of other four proteins were similar to the change patterns of their corresponding proteins in iTRAQ analysis.

![Western blot analysis of selected differentially abundant proteins in cytoplasmic and nuclear fractions of IBDV‐infected cells. The differentially abundant proteins NF45 was increased in the cytoplasmic fraction and translocated from nucleus to the cytoplasm upon virus infection. Equal amounts of protein fractions were loaded, and the abundance of IFIT5, hnRNPH1, NF45, API5, STAT1, and viral protein VP3 were determined using specific pAbs/mAbs. Mock‐infected cells were used as a negative control. GAPDH and histone 3 were used as the marker and loading control for the cytoplasm and nucleus, respectively.](ELPS-36-1596-g005){#elps5490-fig-0005}

3.6. Colocalization of viral protein VP3 with host protein {#elps5490-sec-0190}
----------------------------------------------------------

Confocal microscopy can be used to monitor not only the subcellular localization of proteins, but also changes in protein abundance [28](#elps5490-bib-0028){ref-type="ref"}. Thus, several quantitative proteomics studies have employed confocal microscopy to validate their MS results [25](#elps5490-bib-0025){ref-type="ref"}, [29](#elps5490-bib-0029){ref-type="ref"}. In our study, colocalization analysis was performed by the double staining indirect immunofluorescence assay (IFA) analysis using the pAbs to NF45, hnRNPH1, DDX42, NPL4, and API5, and the mAb to VP3 protein of IBDV. In mock‐infected cells (Supporting Information Fig. 3), hnRNPH1, API5, and NPL4 were mainly expressed in the cytoplasm, while NF45 and DDX42 appeared in the nucleus. Distribution patterns of the above‐mentioned cytoplasmic proteins in IBDV‐infected cells were the same as those in mock‐infected cells, but the fluorescence intensities of these proteins were increased in infected cells compared with mock‐infected cells. In IBDV‐infected cells at 24 h after inoculation, the VP3 viral protein signal overlapped with that of NF45, hnRNPH1, DDX42, NPL4, and API5 (Fig. [6](#elps5490-fig-0006){ref-type="fig"}). Interestingly, NF45 and DDX42, which are normally expressed in the nucleus, were colocalized with the viral protein VP3 in the cytoplasm of IBDV‐infected cells, indicating that NF45 and DDX42 were translocated from the nucleus to cytoplasm during infection. Moreover, the abundance of NF45 clearly increased and accumulated in the cytoplasm of IBDV‐infected cells.

![Immunofluorescence analysis of subcellular distribution of cellular NF45, hnRNPH1, DDX42, NPL4, and API5 with IBDV VP3 protein by confocal microscopy. IBDV‐infected DF‐1 cells reacted with anti‐VP3 mAb and anti‐hnRNPH1, anti‐NF45, anti‐API5, anti‐NPL4, or anti‐DDX42 pAbs as a primary antibody, followed by the FITC‐conjugated (green) goat/rabbit IgG and Alexa Fluor 546 conjugated (red) mouse IgG. The fixed cell nuclei were stained with DAPI (blue).](ELPS-36-1596-g006){#elps5490-fig-0006}

3.7. Network analysis of differentially abundant proteins {#elps5490-sec-0200}
---------------------------------------------------------

We constructed the pathways of differentially abundant proteins by canonical pathway analysis. For the pathway analysis, 11 canonical pathways were affected significantly during IBDV infection (*p* ≤ 0.05). As shown in Fig. [7](#elps5490-fig-0007){ref-type="fig"}A, telomere extension by telomerase (*p* = 3.51 × 10^−4^, ratio 0.111) was the top priority in the cytoplasmic proteome, other favored the role of p14/p19ARF in tumor suppression (*p* = 1.43 × 10^−3^, ratio 0.057) and inosine‐5′‐phosphate biosynthesis II (*p* = 5.6 × 10^−3^, ratio 0.062). Meanwhile, the ratio in telomere extension by telomerase pathway showed the most significant among the ten canonical pathways. Additionally, the nuclear proteome (Fig. [7](#elps5490-fig-0007){ref-type="fig"}B) tended to heavily favor eIF2 signaling as the primary pathway (*p* = 1.09 × 10^−4^, ratio 0.025), which is highly conserved and vitally important for antiviral responses [30](#elps5490-bib-0030){ref-type="ref"}. Other significant associations included gluconeogenesis I, intrinsic prothrombin activation pathway, and mitochondrial dysfunction (Fig. [7](#elps5490-fig-0007){ref-type="fig"}B).

![Signaling pathways in subcellular fractions significantly affected by virus infection. (A) Top 11 signaling pathways in the cytoplasmic proteome. (B) Top 10 signaling pathways in the nuclear proteome. Cononical pathway analysis were conducted by IPA software. The pathway involved was shown by *p*‐value of regulated proteins. The ratio represented that number reached threshold criteria divided total number of the given pathway.](ELPS-36-1596-g007){#elps5490-fig-0007}

In order to determine how IBDV interacts with the host proteins and how they affect cellular functions, we constructed virus--host interaction networks by IPA. Network maps of both cytoplasmic proteins and nuclear proteins were created (Fig. [8](#elps5490-fig-0008){ref-type="fig"}A and B). For the network analysis, cytoplasmic proteins involved in RNA posttranscriptional modification, molecular transport, and RNA trafficking were grouped together (Fig. [8](#elps5490-fig-0008){ref-type="fig"}A). Most of the cytoplasmic proteins were linked to the mTOR signaling, ERK/MAPK signaling, and protein ubiquitination pathways. Additionally, in the nuclear fraction, proteins involved in DNA replication, repair, cell‐mediated immune response, and cellular development were grouped together (Fig. [8](#elps5490-fig-0008){ref-type="fig"}B). The bioinformatic analysis suggests that the PI3K/Akt signaling pathway and IFN‐β signaling cascades are vitally involved in IBDV infection. Certain proteins increased in abundance in infected cells are known to be products of IFNs, such as IFIT5 [27](#elps5490-bib-0027){ref-type="ref"}, [31](#elps5490-bib-0031){ref-type="ref"} and STAT1 [32](#elps5490-bib-0032){ref-type="ref"}, [33](#elps5490-bib-0033){ref-type="ref"}, which implies a specific antiviral response in the host cells. Due to limitations of the database or unknown functions of the host protein, some of the differentially abundant proteins were not included in this network.

![Analysis of interaction network pathway for identified proteins in cytoplasmic fraction (A) and nuclear fraction (B). Proteins that were found to be increased or decreased in abundance in the cytoplasmic or nuclear fraction were submitted to network analysis using Ingenuity Systems. Green color indicated proteins showing 0.83 or greater decrease in abundance, and red color showing 1.2 or greater increase in IBDV‐infected cells. Different shapes represented different functional class of the proteins. Solid lines and dashed lines indicated, respectively, direct or indirect molecular interaction.](ELPS-36-1596-g008){#elps5490-fig-0008}

4. Discussion {#elps5490-sec-0210}
=============

Reliable quantitative methods are essential in biomarker discovery and to interpret proteomic data. In recent years, subcellular prefractionation has been employed as a popular technique to reduce sample complexity, extend protein coverage, and more critically, to provide a spatial description of proteins in the cell. Understanding virus--host interactions is critical for elucidating molecular mechanisms associated with functional alterations of IBDV‐infected cells. Until now, no study had examined the subcellular proteome of IBDV‐infected cells, although proteomic analyses of in vitro IBDV‐infected CEFs [6](#elps5490-bib-0006){ref-type="ref"} and in vivo IBDV‐infected bursa of Fabricius [9](#elps5490-bib-0009){ref-type="ref"} from our research group were previously reported. In the current work, we used a subcellular iTRAQ proteomic approach to characterize differentially abundant proteins in the cytoplasmic/nuclear fractions of IBDV‐infected DF‐1 cells. Comparative analysis of the results by MS revealed that in the cytoplasmic proteome of virus‐infected cells, altered cellular proteins included 17 increased proteins in abundance and six decreased proteins in abundance. In the nuclear proteome, 34 altered cellular proteins were identified, including 14 increased proteins in abundance and 20 decreased proteins in abundance. Additionally, IFA showed the interplay between the viral protein VP3 and cellular protein NF45. Clearly, further studies are necessary to understand the roles of the altered cellular proteins in IBDV infection. Possible biological functions and pathways associated with these differentially abundant proteins were explored by the IPA package, and the identified cellular proteins were found to be mainly involved in immune system process, biological regulation, molecular transport, signaling, and metabolic process.

In present study, except for that two altered proteins were found identical in IBDV‐infected CEF cells by 2DE and iTRAQ, we also found that most of the differentially increased proteins in abundance were different in comparison with our previous research reports using 2DE [6](#elps5490-bib-0006){ref-type="ref"}, [9](#elps5490-bib-0009){ref-type="ref"}. We identified more cytosolic and nuclear proteins with iTRAQ‐based quantitative subcellular proteomics. Proteins not identified in previous 2DE proteomics included IFIT5, NF45, STAT1, and API5 involved in immune response and cellular apoptosis. Apart from this, RNA processing and energy metabolism related proteins hnRNP H1, DDX42, and DDX1 also were supplemented from our data. Generally, the iTRAQ method provided the finer details of the subcellular proteome of IBDV‐infected cells, and more information for different compartments of host cells. To our knowledge, this study is the first to report a subcellular proteomic analysis of the response to IBDV infection.

*IFIT* genes encode a family of proteins that are induced after IFN treatment, viral infection, or PAMP recognition [34](#elps5490-bib-0034){ref-type="ref"}. IFIT proteins are poised to confer inhibitory effects after infection, and they have been found to be increased in abundance in target cells infected with various viruses, such as H3N2 swine influenza virus [11](#elps5490-bib-0011){ref-type="ref"}, Japanese encephalitis virus (JEV) [35](#elps5490-bib-0035){ref-type="ref"}, and porcine reproductive and respiratory syndrome virus [16](#elps5490-bib-0016){ref-type="ref"}. Recently, progress was made in identifying how IFIT proteins inhibit through distinct mechanisms of action, and the replication of multiple families of viruses [36](#elps5490-bib-0036){ref-type="ref"}, such as hepatitis C virus [37](#elps5490-bib-0037){ref-type="ref"}, influenza A virus, and vesicular stomatitis virus [38](#elps5490-bib-0038){ref-type="ref"}. One of the IFIT family genes, *IFIT5* (*ISG58*), is involved in anti‐viral responses through enhancing innate immune signaling pathways [27](#elps5490-bib-0027){ref-type="ref"}. In the present study, IFIT5 was revealed to be increased in abundance during IBDV infection (increased ∼2.001‐fold in the cytoplasmic fraction). Therefore, it is conceivable that IFIT5 may be an important modulator in the antivial innate immune response during IBDV infection. STAT1 is a downstream target of the IFN pathway, which is central to the regulation of immune responses in viral invasion. Type I IFN binds to a common IFN‐α/β receptor that initiates a signaling cascade that results in the phosphorylation and nuclear translocation of STAT1 and the induction of the expression of hundreds of IFN‐stimulated genes [33](#elps5490-bib-0033){ref-type="ref"}, [39](#elps5490-bib-0039){ref-type="ref"}. In the present study, STAT1 was notably upregulated during IBDV infection. However, the upregulated mechanism of STAT1 needs further investigation in IBDV‐infected DF‐1 cells.

Our analysis found increased abundance of the RNA processing and translation‐associated gene *hnRNPH1* in the cytoplasmic fraction of IBDV‐infected cells. As RNA binding proteins, hnRNPs are associated with pre‐mRNAs in the nucleus and appear to influence pre‐mRNA processing and other aspects of mRNA metabolism and transport [40](#elps5490-bib-0040){ref-type="ref"}, [41](#elps5490-bib-0041){ref-type="ref"}, [42](#elps5490-bib-0042){ref-type="ref"}. Previous reports have shown that poliovirus infection cause redistribution of the cellular hnRNPs A1 and K from the nucleus to the cytoplasm [43](#elps5490-bib-0043){ref-type="ref"}, and hnRNP U is colocalized with vesicular stomatitis virus [44](#elps5490-bib-0044){ref-type="ref"}. HnRNP H1 has also been implicated in assisting hepatitis C virus replication [41](#elps5490-bib-0041){ref-type="ref"}. Moreover, confocal microscopy analysis showed colocalization of hnRNP H1 protein with the viral protein VP3 in the cytoplasm of IBDV‐infected cells (Fig. [6](#elps5490-fig-0006){ref-type="fig"}B). VP3 has multiple functions that contribute to efficient virus replication [45](#elps5490-bib-0045){ref-type="ref"}. Therefore, we hypothesized that the increased abundance of hnRNP H1 may play an important role in the replication of IBDV. Among the differentially abundant proteins, we also found decrease in abundance of cellular proteins associated with RNA processing and biosynthesis, including 60S ribosomal protein l5 (RPL5, for RNA binding) and malate dehydrogenase 2 (MDH2, operates the metabolic coordination between cytosol and mitochondria). Notably the proteomic data further revealed that the key glycolytic enzymes, including aldolase C (ALDOC), were extensively decreased in abundance. Based on these proteomic analyses, we speculate that IBDV replication may extensively inhibit the host cellular metabolic pathways involved in glycolysis and energy metabolism as well as mRNA processing.

We also found differentially abundant proteins associated with DEAD‐box RNA helicases DDX1 and DDX42 (Fig. [6](#elps5490-fig-0006){ref-type="fig"}), which are involved in many aspects of RNA metabolism. Additionally, DDX1 was shown to be an RNA‐activated ATPase, wherein Rev‐bound RNA was equally effective at stimulating ATPase activity as protein‐free RNA. DDX1 interacted with HIV‐1 Rev and involved in virus replication in Hela cells [46](#elps5490-bib-0046){ref-type="ref"}. Moreover, DDX1 interacted with NF‐κB subunit RelA (p65) and took part in regulating NF‐κB‐mediated regulatory pathway [47](#elps5490-bib-0047){ref-type="ref"}. Futhermore, the study found that DDX1 interacted with nsp14 from both coronavirus infectious bronchitis virus (IBV) and severe acute respiratory syndrome coronavirus (SARS‐CoV). Intranuclear DDX1 was translocated to cytoplasm in IBV‐infected Vero cells. In other words, DDX1 was conducive to enhance coronavirus replication [48](#elps5490-bib-0048){ref-type="ref"}. ATP‐dependent RNA helicase DDX42 interacted with JEV NS4A in vitro and in vivo. Importantly, the expression of DDX42 inhibited the confrontation of the response to IFN‐β by JEV [49](#elps5490-bib-0049){ref-type="ref"}. Together, these results provided insight into the understanding of IBV pathogenesis.

NF45, also known as ILF2, has been indicated to act as an important regulatory factor involved in transcription, microRNA processing, nuclear export of RNAs, and posttranscriptional and translational regulation of gene expression [50](#elps5490-bib-0050){ref-type="ref"}, [51](#elps5490-bib-0051){ref-type="ref"}, [52](#elps5490-bib-0052){ref-type="ref"}. NF45/NF90 heterodimeric protein complex have involved multitudinous functions, one of the functions was transferred from the nuclear to the cytoplasm in many different cell types [53](#elps5490-bib-0053){ref-type="ref"}. In the infected DF‐1 cells, we found predominantly the NF45 protein in the cytoplasmic fraction (Fig. [6](#elps5490-fig-0006){ref-type="fig"}). In addition, we also found that NF45 colocalized with VP3 and translocated from the nucleus to cytoplasm during IBDV infection (Fig. [6](#elps5490-fig-0006){ref-type="fig"}). This observation was similar to a previous observation of IBDV infection at 12 hpi [54](#elps5490-bib-0054){ref-type="ref"} and consistent with the conclusion that the cytoplasmic accumulation of NF45 as a consequence of the viral infection occurs independently from the expression of IFN‐regulated genes.

Some proteins associated with cell death and apoptosis, such as API5, was identified as being altered by IBDV infection. API5 is an antiapoptotic protein that is increased in abundance in various cancer cells, the roles of API5 may be to mediate protein--protein interactions [55](#elps5490-bib-0055){ref-type="ref"}. Morris et al. [56](#elps5490-bib-0056){ref-type="ref"} reported that API5 play an important role in dE2F1‐induced apoptosis. Proviral integration of moloney virus‐2 can activate API5 through phosphorylation mechanism in order to inhibit the apoptosis of liver cells, and NF‐κB is the key regulator in this antiapoptotic pathway [57](#elps5490-bib-0057){ref-type="ref"}. The antioxidant stress protein PRDX4 was decreased in abundance, suggesting that IBDV‐infected inhibits host cell oxidative stress. Virus‐induced oxidative stress is associated with the activation of phagocytosis and the release of reactive oxygen that positively modulate the immune activation and eradicate viral infection and immune‐induced cellular injury [58](#elps5490-bib-0058){ref-type="ref"}. Moreover, Tavender et al. [59](#elps5490-bib-0059){ref-type="ref"} found that PRDX4, an endoplasmic reticulum localized peroxiredoxin and known to play an important role in disulfide formation, can be associated with the endoplasmic reticulum stress response.

In addition, among the differentially abundant proteins, we identified nucleolar protein nucleophosmin 1 (NPM1) in the cytoplasmic fraction. NPM1 has been linked to a variety of important cellular processes, both in and out of the nucleolus, including ribosome processing, molecular chaperoning, maintenance of genomic integrity, centrosome duplication, and transcriptional regulation [60](#elps5490-bib-0060){ref-type="ref"}, [61](#elps5490-bib-0061){ref-type="ref"}. It has been reported to function as a chaperone in the viral chromatin assembly process in infected cells [62](#elps5490-bib-0062){ref-type="ref"}. This shuttling of proteins between the nucleus and cytoplasm is now recognized as a key mechanism for ensuring proper cell cycle progression [63](#elps5490-bib-0063){ref-type="ref"}. In previous report, others have identified NPM as a novel p53‐independent target of the ARF tumor suppressor protein [64](#elps5490-bib-0064){ref-type="ref"}. Our investigation demonstrated an increased level of NPM1 in IBDV‐infected DF‐1 cells, which can be hypothesized as an attempt by the host to arrest viral replication inside the cells.

As demonstrated in this study, we first use iTRAQ subcellular proteomic analysis to understand DF‐1 cell responses of IBDV infection. Using accurate methods, a total of 57 cellular proteins that were significantly altered postinfection were identified. These data provide clues to elucidate the molecular mechanisms of the interaction between IBDV and target cells.

 {#elps5490-sec-0230}
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Figure S1. Workflow of samples labeling with iTRAQ reagents.
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Click here for additional data file.
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Figure.S2. MS/MS spectrum for each protein in Table 1 identified on the basis of one unique peptide.
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Click here for additional data file.

###### 

Figure S3. Confocal microscopy analysis of identified proteins NF45, hnRNPH1, DDX42, NPL4 and API5 in mock‐infected cells. Mock‐infected cells were immunostained with rabbit/goat antibodies against NF45, hnRNPH1, DDX42, NPL4 or API5, and then probed with the FITC‐conjugated (green) goat/rabbit IgG. Cell nuclei were stained with DAPI (blue). Merged images show the cytosolic or nuclear localization of the proteins.
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Click here for additional data file.
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Table 1. Differentially Abundant Proteins in IBDV‐infected DF‐1 cells by iTRAQ Analysis

Table S1. Specific primers suited to amplifying various target genes. These genes were designed according to the corresponding gene sequences of LC‐MS/MS identified proteins and the available gene information deposited in the Genbank library by using laser gene sequence analysis software (DNAStar, Madison, WI).

###### 

Click here for additional data file.

*The MS proteomics data have been deposited to the ProteomeXchange Consortium \[65\] via the PRIDE partner repository with the dataset identifier PXD001869. This work was supported by grants from China Agriculture Research System (grant no. CARS‐41‐K11), National Key Technology R & D Program of China (grant no. 2015BAD12B01), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors thank Jianwen Hu (Shanghai Applied Protein Technology Co., China) for help with LC‐MS/MS. Besides, they are grateful to Yang Zhang for kindly providing the protein network (Institutes of Biomedical Sciences, Fudan University)*.

[^1]: Additional corresponding author: Dr. Xiaojuan Zheng E‐mail: <zhengxiaojuan@zju.edu.cn>
